Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Eur Rev Med Pharmacol Sci ; 23(20): 8841-8851, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31696471

ABSTRACT

OBJECTIVE: To provide biomarkers related to the radiation response of patients to avoid unnecessary side effects on those who were not sensitive to radiotherapy. PATIENTS AND METHODS: In the present study, we compared the different four proteins (PDIA3, Vimentin, Galectin3, Dhe3) patterns in rectal tumor tissue before and after radiation therapy by using 2-D PAGE, mass spectrometry, and bioinformatics analysis. RESULTS: The protein level of Galectin3 and PDIA3 were downregulated in rectal cancer patients before and after radiotherapy (1.42 folds); while Dhe3 protein and Vimentin were upregulated (1-2 folds), and we also revealed Vimentin as its role in the negative regulation of the well-known transcription factor ATF4. CONCLUSIONS: Our study showed that four candidate proteins, including PIDA3, Galectin3, Dhe3, and Vimentin, might be the potential biomarkers in the identification of radiation response in rectal cancer.


Subject(s)
Biomarkers, Tumor/metabolism , Proteomics/methods , Rectal Neoplasms/pathology , Activating Transcription Factor 4/metabolism , Adult , Down-Regulation , Female , Galectin 3/metabolism , Humans , Male , Middle Aged , Protein Disulfide-Isomerases/metabolism , Protein Interaction Maps , Rectal Neoplasms/metabolism , Rectal Neoplasms/radiotherapy , Up-Regulation , Vimentin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL